• Journals Master List
  • DOAJ
  • 数据库logo
  • EuroPub
GAN Jing, ZHANG Xin-zhi, WU Yan-sheng, XU Li, LU Li-li, GAO Jian-dong. Investigation and analysis of anemia incidence in patients with polycystic kidney disease[J]. Journal of Clinical Nephrology, 2020, 20(3): 203-206. DOI: 10.3969/j.issn.1671-2390.2020.03.006
Citation: GAN Jing, ZHANG Xin-zhi, WU Yan-sheng, XU Li, LU Li-li, GAO Jian-dong. Investigation and analysis of anemia incidence in patients with polycystic kidney disease[J]. Journal of Clinical Nephrology, 2020, 20(3): 203-206. DOI: 10.3969/j.issn.1671-2390.2020.03.006

Investigation and analysis of anemia incidence in patients with polycystic kidney disease

More Information
  • Received Date: October 30, 2019
  • Available Online: May 11, 2023
  • Published Date: March 27, 2020
  • Objective To investigate the incidence of anemia in patients with polycystic kidney disease (PKD) and its risk factors. Methods Clinical data of 161 PKD patients visiting in Department of Nephrology of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine from September 2017 to October 2019 were collected, the prevalence of anemia in PKD patients was investigated, and the risk factors of anemia were statistically analyzed. Results The incidence rate of anemia in 161 PKD patients was 70.81%. In different age groups, the anaemia rates of patients at the ages below 30, between 30~50, between 50~70 and above 70 were 40.00%, 53.62%, 86.42% and 83.33%,respectively. The anaemia rates of patients with chronic kidney disease (CKD) stage 1~5 were 20.00%, 57.14%, 49.06%, 86.49% and 97.87%,respectively (P<0.01). The anemic rates of dialysis group and non-dialysis group at CKD5 stage were 93.75% and 100.00% respectively. Univariate analysis showed that age, CKD stage and dialysis were correlated with the incidence of anemia, while multivariate Logistic regression analysis indicated that only CKD stage was significantly correlated with the incidence of anemia (P<0.001).Conclusions Anemia in patients with PKD is aggravated with the progression of renal function damage. Therefore, enhanced intervention and timely treatment should be performed at the early stage of CKD.
  • [1]
    Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease[J]. Lancet, 2019, 393(10174):919-935. DOI: 10.1016/S0140-6736(18)32782-X.
    [2]
    陈欢欢. 200例成人型多囊肾病患者临床特征分析及中医证候研究[D].广州:广州中医药大学, 2016.
    [3]
    Racki S, Maleta I. Role of renal anemia in progression of chronic kidney disease[J]. Acta Med Croatica, 2009, 63, Suppl 1(6):33-37.
    [4]
    Czarnecki PG, Steinman TI. Polycystic kidney disease:new horizons and therapeutic frontiers[J].Italian J Urol Nephrol, 2013, 65(1):61-68.DOI: 10.1038/aja.2012.129.
    [5]
    Alam A, Perrone RD. Management of ESRD in patients with autosomal dominant polycystic kidney disease[J]. AdvChronic Kidney Dis, 2010, 17(2):164-172. DOI: 10.1053/j.ackd.2009.12.006.
    [6]
    黎磊石,刘志红.中国肾脏病学[M].北京:人民军医出版社, 2008:1018.
    [7]
    Riella MC. Kidney disease:Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease[J]. Kidney International Supplements, 2013, 3(1):1-150.DOI: 10.1038/kisup.2012.73.
    [8]
    Mcdonald RA.KDIGO clinical practice guideline for anemia in chronic kidney disease[J]. Kidney International Supplements, 2012, 2(4):279-335.DOI: 10.1038/kisup.2012.1.
    [9]
    Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009,150(9):604-612. DOI: 10.7326/0003-4819-150-9-200905050-00006.
    [10]
    施善芬,黎良达,潘翠萍,等.常染色体显性遗传多囊肾病患者贫血情况分析[J].中国医刊, 2013, 48(3):62-63. DOI: 10.3969/j.issn.1008-1070.2013.03.022.
    [11]
    李静.浅析进行血液透析的患者发生失血的原因及对策[J].当代医药论丛, 2017, 15(16):269-271. DOI: 10.3969/j.issn.2095-7629.2017.16.197.
    [12]
    Tozoni SS, Dias GF, Bohnen G, et al. Uremia and hypoxia independently induce eryptosis and erythrocyte redox imbalance[J]. Cell PhysiolBiochem, 2019, 53:794-804. DOI: 10.33594/000000173.
    [13]
    Awan AA, Walther CP, Richardson PA, et al. Prevalence, correlates and outcomes of absolute and functional iron deficiency Anemia in nondialysis-dependent chronic kidney disease[J].Nephrol Dial Transplant, 2019:gfz192. DOI: 10.1093/ndt/gfz192.
    [14]
    Yeh SC, Lin YC, Hong YC, et al. Different effects of iron indices on mortality in patients with autosomal dominant polycystic kidney disease after long-term hemodialysis:anationwide population-based study[J]. J Ren Nutr, 2019, 29(5):444-453. DOI: 10.1053/j.jrn.2018.11.004.
    [15]
    Hatamizadeh P, Ravel V, Lukowsky LR, et al. Iron indices and survival in maintenance hemodialysis patients with and without polycystic kidney disease[J].Nephrol Dial Transplant, 2013, 28(11):2889-2898. DOI: 10.1093/ndt/gft411.
    [16]
    王艳丽.慢性肾脏病患者贫血现况的调查及其分析[J].湖北中医杂志, 2016, 38(5):16-18.

Catalog

    Article views (482) PDF downloads (430) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return